Pediatric Obesity and the Risk of Multiple Sclerosis: a Nationwide Prospective Cohort Study

Overview

Journal Int J Obes (Lond)

Date 2025 Jan 30

PMID 39885338

Authors

Emilia Hagman

Resthie R Putri

Pernilla Danielsson

Claude Marcus

Affiliations

Soon will be listed here.

Abstract

Background: Emerging evidence implies a link between high pediatric body mass index (BMI) and an increased risk of multiple sclerosis (MS). However, previous research suggests this association is only present for adolescent obesity and not childhood obesity. The present study aimed to assess the association between pediatric obesity and risk of developing MS, and to investigate if degree of obesity and age at obesity treatment initiation affects the risk. In a subgroup, response to obesity treatment on MS risk was assessed.

Methods: In this cohort study, patients aged 2-19 years from the Swedish Childhood Obesity Treatment Register (BORIS), and matched individuals from the general population were followed prospectively. MS was identified through the National Patient Register. Hazard ratios (HR) adjusted for parental MS were calculated.

Results: The study included 21,652 individuals with pediatric obesity and 102,187 general population comparators. The median age at follow-up was 21 (Q1, Q3 18, 25) years. The adjusted HR (95% CI) for developing MS in the pediatric obesity cohort was 2.28 (1.45-3.58). In stratified analyses, obesity class I was not associated with MS, HR = 1.34 (0.64-2.81), while the association between obesity class II and MS was strengthened, HR = 3.42 (1.89-6.19). MS was associated with both childhood obesity, HR = 3.16 (1.12-8.87), and adolescent obesity, HR = 2.12 (1.28-3.51). A decrease in BMI SDS was not associated with lower likelihood of MS, HR = 1.09 (0.92-1.29) per 0.25 BMI SDS unit decrease.

Conclusions: Both childhood and adolescent obesity are associated with an increased risk of MS. Moreover, a dose-response relationship between the degree of obesity and the risk of future MS was indicated, while response to pediatric obesity treatment did not affect the association, highlighting the importance of preventing high degree of obesity early in life.

References

Lindberg L, Danielsson P, Persson M, Marcus C, Hagman E . Association of childhood obesity with risk of early all-cause and cause-specific mortality: A Swedish prospective cohort study. PLoS Med. 2020; 17(3):e1003078. PMC: 7080224. DOI: 10.1371/journal.pmed.1003078. View

Marcus C, Danielsson P, Hagman E . Pediatric obesity-Long-term consequences and effect of weight loss. J Intern Med. 2022; 292(6):870-891. PMC: 9805112. DOI: 10.1111/joim.13547. View

Lindberg L, Hagman E, Danielsson P, Marcus C, Persson M . Anxiety and depression in children and adolescents with obesity: a nationwide study in Sweden. BMC Med. 2020; 18(1):30. PMC: 7033939. DOI: 10.1186/s12916-020-1498-z. View

Lindberg L, Persson M, Danielsson P, Hagman E, Marcus C . Obesity in childhood, socioeconomic status, and completion of 12 or more school years: a prospective cohort study. BMJ Open. 2021; 11(3):e040432. PMC: 7957136. DOI: 10.1136/bmjopen-2020-040432. View

Munger K, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sorensen T . Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013; 19(10):1323-9. PMC: 4418015. DOI: 10.1177/1352458513483889. View

Hedstrom A, Olsson T, Alfredsson L . High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 2012; 18(9):1334-6. DOI: 10.1177/1352458512436596. View

Pakpoor J, Schmierer K, Cuzick J, Giovannoni G, Dobson R . Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment. Int J Epidemiol. 2020; 49(6):2051-2057. DOI: 10.1093/ije/dyaa151. View

Marrodan M, Farez M, Balbuena Aguirre M, Correale J . Obesity and the risk of Multiple Sclerosis. The role of Leptin. Ann Clin Transl Neurol. 2020; 8(2):406-424. PMC: 7886048. DOI: 10.1002/acn3.51291. View

Hedstrom A, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I . Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014; 82(10):865-72. PMC: 3959752. DOI: 10.1212/WNL.0000000000000203. View

10.

Harroud A, Mitchell R, Richardson T, Morris J, Forgetta V, Davey Smith G . Childhood obesity and multiple sclerosis: A Mendelian randomization study. Mult Scler. 2021; 27(14):2150-2158. DOI: 10.1177/13524585211001781. View

11.

Hedstrom A, Olsson T, Alfredsson L . Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler. 2015; 22(7):878-83. DOI: 10.1177/1352458515603798. View

12.

Olsson T, Barcellos L, Alfredsson L . Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2016; 13(1):25-36. DOI: 10.1038/nrneurol.2016.187. View

13.

Munger K, Chitnis T, Ascherio A . Body size and risk of MS in two cohorts of US women. Neurology. 2009; 73(19):1543-50. PMC: 2777074. DOI: 10.1212/WNL.0b013e3181c0d6e0. View

14.

Cole T, Lobstein T . Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012; 7(4):284-94. DOI: 10.1111/j.2047-6310.2012.00064.x. View

15.

Hagman E, Danielsson P, Lindberg L, Marcus C . Paediatric obesity treatment during 14 years in Sweden: Lessons from the Swedish Childhood Obesity Treatment Register-BORIS. Pediatr Obes. 2020; 15(7):e12626. DOI: 10.1111/ijpo.12626. View

16.

Ludvigsson J, Almqvist C, Edstedt Bonamy A, Ljung R, Michaelsson K, Neovius M . Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016; 31(2):125-36. DOI: 10.1007/s10654-016-0117-y. View

17.

Murley C, Friberg E, Hillert J, Alexanderson K, Yang F . Validation of multiple sclerosis diagnoses in the Swedish National Patient Register. Eur J Epidemiol. 2019; 34(12):1161-1169. PMC: 7010617. DOI: 10.1007/s10654-019-00558-7. View

18.

Montgomery T, Peipert D, Krementsov D . Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet. Immunol Rev. 2024; 325(1):131-151. PMC: 11338732. DOI: 10.1111/imr.13343. View

19.

Sawyer S, Azzopardi P, Wickremarathne D, Patton G . The age of adolescence. Lancet Child Adolesc Health. 2018; 2(3):223-228. DOI: 10.1016/S2352-4642(18)30022-1. View

20.

Ji Z, Wu S, Xu Y, Qi J, Su X, Shen L . Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration. Front Immunol. 2019; 10:1881. PMC: 6718738. DOI: 10.3389/fimmu.2019.01881. View